Showing results (241-250 of 413) with videos related to

Sort By:
Pageof 42
Cellular Signalling|February 12, 2008
Protein kinase D2 regulates chromogranin A secretion in human BON neuroendocrine tumour cellsGötz von Wichert, Teresa Edenfeld, Julia von Blume, et al.
Carcinogenesis|January 10, 2020
Sildenafil triggers tumor lethality through altered expression of HSP90 and degradation of PKD2Lu Chen, Yang Liu, Alexander Becher, et al.
The Journal of Clinical Endocrinology and Metabolism|January 31, 2015
Telotristat etiprate for carcinoid syndrome: a single-arm, multicenter trialMarianne Pavel, Dieter Hörsch, Martyn Caplin, et al.
Frontiers in Pharmacology|May 24, 2021
CYP2D6 in the Brain: Potential Impact on Adverse Drug Reactions in the Central Nervous System-Results From the ADRED StudyKatja S Just, Harald Dormann, Mathias Freitag, et al.
Acta Oncologica (Stockholm, Sweden)|September 13, 2013
Docetaxel, oxaliplatin and capecitabine (TEX regimen) in patients with metastatic gastric or gastro-esophageal cancer: results of a multicenter phase I/II studyAlexander Stein, Dirk Arnold, Peter C Thuss-Patience, et al.
Cytoskeleton (Hoboken, N.J.)|January 27, 2015
Phosphorylation and turnover of paxillin in focal contacts is controlled by force and defines the dynamic state of the adhesion siteRuifang Qin, Heidrun Schmid, Christin Münzberg, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|July 25, 2020
FAK inhibition radiosensitizes pancreatic ductal adenocarcinoma cells in vitroA Allam Mohamed, Andreas Thomsen, Marie Follo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 30, 2008
Phase I trial of the human immunodeficiency virus protease inhibitor nelfinavir and chemoradiation for locally advanced pancreatic cancerThomas B Brunner, Matthias Geiger, Gerhard G Grabenbauer, et al.
Pageof 42